“…In response to this need, the Coronavirus Anxiety Scale (CAS) was designed with the aim of evaluating the dysfunctional experience of anxiety related to COVID-19 (Lee, 2020). This scale has demonstrated strong psychometric properties and has been used, as far as we know, in countries such as the United States (Lee, 2020;, Turkey (Evren et al, 2020), Bangladesh (Ahmed et al, 2020), Mexico (Mora-Magaña et al, 2020), Pakistan (Ashraf et al, 2020), Peru (Franco-Jimenez, 2020), and South Korea (Choi et al, 2020).…”